BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 19584865)

  • 1. Alefacept promotes co-stimulation blockade based allograft survival in nonhuman primates.
    Weaver TA; Charafeddine AH; Agarwal A; Turner AP; Russell M; Leopardi FV; Kampen RL; Stempora L; Song M; Larsen CP; Kirk AD
    Nat Med; 2009 Jul; 15(7):746-9. PubMed ID: 19584865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Belatacept and sirolimus prolong nonhuman primate renal allograft survival without a requirement for memory T cell depletion.
    Lo DJ; Anderson DJ; Weaver TA; Leopardi F; Song M; Farris AB; Strobert EA; Jenkins J; Turgeon NA; Mehta AK; Larsen CP; Kirk AD
    Am J Transplant; 2013 Feb; 13(2):320-8. PubMed ID: 23311611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective targeting of human alloresponsive CD8+ effector memory T cells based on CD2 expression.
    Lo DJ; Weaver TA; Stempora L; Mehta AK; Ford ML; Larsen CP; Kirk AD
    Am J Transplant; 2011 Jan; 11(1):22-33. PubMed ID: 21070604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Belatacept and sirolimus prolong nonhuman primate islet allograft survival: adverse consequences of concomitant alefacept therapy.
    Lowe MC; Badell IR; Turner AP; Thompson PW; Leopardi FV; Strobert EA; Larsen CP; Kirk AD
    Am J Transplant; 2013 Feb; 13(2):312-9. PubMed ID: 23279640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alefacept promotes immunosuppression-free renal allograft survival in nonhuman primates via depletion of recipient memory T cells.
    Lee S; Yamada Y; Tonsho M; Boskovic S; Nadazdin O; Schoenfeld D; Cappetta K; Atif M; Smith RN; Cosimi AB; Benichou G; Kawai T
    Am J Transplant; 2013 Dec; 13(12):3223-9. PubMed ID: 24165326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Effect of ASP2409, a Novel CD86-Selective Variant of CTLA4-Ig, on Renal Allograft Rejection in Nonhuman Primates.
    Oshima S; Karrer EE; Kawato Y; Maeda M; Fukahori H; Tsujimoto S; Hirose J; Nakamura K; Marui T; Takamura F; Noto T; Chapin SJ; Fujii Y; Neighbors M; Viswanathan S; Devens BH; Higashi Y
    Transplantation; 2016 Dec; 100(12):2611-2620. PubMed ID: 27861289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ASP2409, A Next-Generation CTLA4-Ig, Versus Belatacept in Renal Allograft Survival in Cynomolgus Monkeys.
    Song L; Ma A; Dun H; Hu Y; Fujii Y; Kinugasa F; Oshima S; Higashi Y; Daloze P; Chen H
    Am J Transplant; 2017 Mar; 17(3):635-645. PubMed ID: 27598231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcineurin inhibitor-free CD28 blockade-based protocol protects allogeneic islets in nonhuman primates.
    Adams AB; Shirasugi N; Durham MM; Strobert E; Anderson D; Rees P; Cowan S; Xu H; Blinder Y; Cheung M; Hollenbaugh D; Kenyon NS; Pearson TC; Larsen CP
    Diabetes; 2002 Feb; 51(2):265-70. PubMed ID: 11812731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-CD40 therapy extends renal allograft survival in rhesus macaques.
    Pearson TC; Trambley J; Odom K; Anderson DC; Cowan S; Bray R; Lin A; Hollenbaugh D; Aruffo A; Siadak AW; Strobert E; Hennigar R; Larsen CP
    Transplantation; 2002 Oct; 74(7):933-40. PubMed ID: 12394833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates.
    Kirk AD; Harlan DM; Armstrong NN; Davis TA; Dong Y; Gray GS; Hong X; Thomas D; Fechner JH; Knechtle SJ
    Proc Natl Acad Sci U S A; 1997 Aug; 94(16):8789-94. PubMed ID: 9238056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Donor-Derived Regulatory Dendritic Cell Infusion Maintains Donor-Reactive CD4
    Ezzelarab MB; Lu L; Shufesky WF; Morelli AE; Thomson AW
    Front Immunol; 2018; 9():250. PubMed ID: 29520267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Costimulatory blockade with mTor inhibition abrogates effector T-cell responses allowing regulatory T-cell survival in renal transplantation.
    Bestard O; Cassis L; Cruzado JM; Torras J; Franquesa M; Gil-Vernet S; Lucia M; GrinyĆ³ JM
    Transpl Int; 2011 May; 24(5):451-60. PubMed ID: 21294788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of Alefacept for Preconditioning in Multiply Transfused Pediatric Patients with Nonmalignant Diseases.
    Stenger EO; Chiang KY; Haight A; Qayed M; Kean L; Horan J
    Biol Blood Marrow Transplant; 2015 Oct; 21(10):1845-52. PubMed ID: 26095669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutralizing BAFF/APRIL with atacicept prevents early DSA formation and AMR development in T cell depletion induced nonhuman primate AMR model.
    Kwun J; Page E; Hong JJ; Gibby A; Yoon J; Farris AB; Villinger F; Knechtle S
    Am J Transplant; 2015 Mar; 15(3):815-22. PubMed ID: 25675879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CTLA4-Ig abrogates the anti-globulin response and prolongs cardiac allograft survival after anti-CD2 treatment.
    Stell D; Marshall H; Bradley JA; Bolton EM
    Transpl Immunol; 2003; 12(1):1-7. PubMed ID: 14551027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eomesodermin(lo) CTLA4(hi) Alloreactive CD8+ Memory T Cells Are Associated With Prolonged Renal Transplant Survival Induced by Regulatory Dendritic Cell Infusion in CTLA4 Immunoglobulin-Treated Nonhuman Primates.
    Ezzelarab MB; Lu L; Guo H; Zahorchak AF; Shufesky WF; Cooper DK; Morelli AE; Thomson AW
    Transplantation; 2016 Jan; 100(1):91-102. PubMed ID: 26680373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective Targeting of High-Affinity LFA-1 Does Not Augment Costimulation Blockade in a Nonhuman Primate Renal Transplantation Model.
    Samy KP; Anderson DJ; Lo DJ; Mulvihill MS; Song M; Farris AB; Parker BS; MacDonald AL; Lu C; Springer TA; Kachlany SC; Reimann KA; How T; Leopardi FV; Franke KS; Williams KD; Collins BH; Kirk AD
    Am J Transplant; 2017 May; 17(5):1193-1203. PubMed ID: 27888551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD154 blockade, sirolimus, and donor-specific transfusion prevents renal allograft rejection in cynomolgus monkeys despite homeostatic T-cell activation.
    Pearl JP; Xu H; Leopardi F; Preston E; Kirk AD
    Transplantation; 2007 May; 83(9):1219-25. PubMed ID: 17496539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel immunosuppressive agents in kidney transplantation.
    Cooper JE; Wiseman AC
    Clin Nephrol; 2010 May; 73(5):333-43. PubMed ID: 20420793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulatory dendritic cell infusion prolongs kidney allograft survival in nonhuman primates.
    Ezzelarab MB; Zahorchak AF; Lu L; Morelli AE; Chalasani G; Demetris AJ; Lakkis FG; Wijkstrom M; Murase N; Humar A; Shapiro R; Cooper DK; Thomson AW
    Am J Transplant; 2013 Aug; 13(8):1989-2005. PubMed ID: 23758811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.